| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.25 | 0.1 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.28 | 0.1 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |